First Skin Cancer Treatment in Four Decades Gets European Approval

by Kathy Jones on  August 23, 2011 at 7:27 PM Cancer News
RSS Email Print This Page Comment bookmark
Font : A-A+

The European Medicines Agency has given its licensing approval to the first skin cancer treatment in more than four decades with the drug, known as Ipilimumab, hitting the British market on Monday.
 First Skin Cancer Treatment in Four Decades Gets European Approval
First Skin Cancer Treatment in Four Decades Gets European Approval

Costing in excess of £75,000, ipilimumab is to be injected four times and works by helping the immune system to fight more effectively against the cancer cells.

Though the treatment has been approved by EMA, the British regulatory body, NICE, is yet to approve the availability of the treatment in the NHS.

Stating that the approval presents a major breakthrough in treating skin cancer, the senior lecturer in Medical Oncology at the Christie NHS Foundation Trust, Dr Paul Lorigan said, "The authorization of ipilimumab represents a real advance in the treatment of patients with advanced melanoma as this is the first treatment for 30 years in the UK to extend patients' life expectancy."


Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Boils / Skin Abscess Skin Cancer Cancer and Homeopathy Ultra-Violet Radiation Cancer Facts Pityriasis rosea Cancer Tattoos A Body Art Pemphigus Hives 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive